[(2S,5R)-5-(5-methyl-2,4-dioxopyrimidin-1-yl)-2,5-dihydrofuran-2-yl]methyl benzoate

We are [(2S,5R)-5-(5-methyl-2,4-dioxopyrimidin-1-yl)-2,5-dihydrofuran-2-yl]methyl benzoate CAS:122567-97-9 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name: [(2S,5R)-5-(5-methyl-2,4-dioxopyrimidin-1-yl)-2,5-dihydrofuran-2-yl]methyl benzoate
CAS.NO:122567-97-9
Synonyms:
5'-benzoyl-D4T;
((2S,5R)-5-(5-Methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2,5-dihydrofuran-2-yl)methyl benzoate
Stavudine impurity I
5'-O-benzoyl-2',3'-didehydro-3'-deoxythymidine
Thymidine,2',3'-didehydro-3'-deoxy-,5'-benzoate
5'-Benzoyl-2',3'-dideoxy-2',3'-didehydrothymidine

Molecular Formula:C17H16N2O5
Molecular Weight:328.31900

Physical and Chemical Properties:
Density: 1.324 g / cm3
Boiling point: /
Melting point: /
Flash point: /
Refractive index: 1.59

Specification:
Appearance:white crystalline powder
Purity:≥98%
Moisture Content: ≤0.1%
Impurity: ≤0.05%

Packing:
 25kg  cardboard drum or according to customer specified requirements
Storage:0-6ºC.Stored in a cool and dry well-closed container. Keep away from moisture and strong light/heat.
Application:Intermediates of Stavudine CAS:3056-17-5

[(2S,5R)-5-(5-methyl-2,4-dioxopyrimidin-1-yl)-2,5-dihydrofuran-2-yl]methyl benzoate


Related News: Large pharmaceutical companies are investing a disproportionately large amount of annual revenue in research and development (R&D), according to GlobalData’s Company Financials database.5-Fluoro-2-methoxypyridine Large pharmaceutical companies are investing a disproportionately large amount of annual revenue in research and development (R&D), according to GlobalData’s Company Financials database.4,4'-Diaminodiphenylsulfone Large pharmaceutical companies are investing a disproportionately large amount of annual revenue in research and development (R&D), according to GlobalData’s Company Financials database.1719-57-9 In recent years, with the increasing number of patent medicines whose patents have expired, the variety and quantity of generic drugs have also increased rapidly, which has brought huge market opportunities to the API market and the output of APIs has continued to increase.In recent years, with the increasing number of patent medicines whose patents have expired, the variety and quantity of generic drugs have also increased rapidly, which has brought huge market opportunities to the API market and the output of APIs has continued to increase.

Related Products
Product Name
5-Iodocytidine View Details
methyl arachidonate View Details
Desmopressin View Details
1,3-dicyclohexylcarbodiimide manufacturer 8-Bromo-3-methyl-1H-purine-2,6(3H,7H)-dione manufacturer 2-Chloromethyl-3-Methyl-4-(3-Methoxypropoxy)Pyridine Hydrochloride manufacturer N-(tert-Butoxycarbonyl)-N-methyl-L-valine manufacturer (2R)-2-chlorobutanoic acid manufacturer